Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Trial Profile

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Feb 2016

At a glance

  • Drugs Clofarabine (Primary) ; Cytarabine; Melphalan
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Acronyms BRIDGE
  • Most Recent Events

    • 01 Dec 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 23 Jul 2012 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top